Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Greenberg

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Synergistic Interactions of Molecular and Clinical Advances for Characterizing the Myelodysplastic SyndromesPeter L Greenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Myelodysplastic syndromes: dissecting the heterogeneityPeter L Greenberg
British Journal of Haematology|May 29, 2010
Current therapeutic approaches for patients with myelodysplastic syndromesPeter L Greenberg
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2006
Myelodysplastic syndromes: iron overload consequences and current chelating therapiesPeter L Greenberg
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
The multifaceted nature of myelodysplastic syndromes: clinical, molecular, and biological prognostic featuresPeter L Greenberg
Haematologica|August 5, 2021
Metchnikoff's legacy: the dysplastic nature of innate immunity in myelodysplastic syndromesPeter L Greenberg
Blood|April 1, 2017
The classical nature of distinctive CMML monocytesPeter L Greenberg
British Journal of Haematology|January 23, 2023
Myelodysplastic syndromes, thy name is heterogeneityPeter L Greenberg
Surgical Pathology Clinics|February 4, 2016
Update on Myelodysplastic Syndromes Classification and PrognosisDita Gratzinger, Peter L Greenberg
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
The Impact of Somatic and Germline Mutations in Myelodysplastic Syndromes and Related DisordersRafael Bejar, Peter L Greenberg
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Synergistic Interactions of Molecular and Clinical Advances for Characterizing the Myelodysplastic SyndromesPeter L Greenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Myelodysplastic syndromes: dissecting the heterogeneityPeter L Greenberg
British Journal of Haematology|May 29, 2010
Current therapeutic approaches for patients with myelodysplastic syndromesPeter L Greenberg
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2006
Myelodysplastic syndromes: iron overload consequences and current chelating therapiesPeter L Greenberg
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
The multifaceted nature of myelodysplastic syndromes: clinical, molecular, and biological prognostic featuresPeter L Greenberg
Haematologica|August 5, 2021
Metchnikoff's legacy: the dysplastic nature of innate immunity in myelodysplastic syndromesPeter L Greenberg
Blood|April 1, 2017
The classical nature of distinctive CMML monocytesPeter L Greenberg
British Journal of Haematology|January 23, 2023
Myelodysplastic syndromes, thy name is heterogeneityPeter L Greenberg
Surgical Pathology Clinics|February 4, 2016
Update on Myelodysplastic Syndromes Classification and PrognosisDita Gratzinger, Peter L Greenberg
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
The Impact of Somatic and Germline Mutations in Myelodysplastic Syndromes and Related DisordersRafael Bejar, Peter L Greenberg
Pageof 10